13F

Stock

BioXcel Therapeutics, Inc.

BTAI · held by 41 managers

Reported value

$5.44M

Holders

41

+1 new · −2 exited

Holders’ est. mark

−$6.99K

Price effect on 3 books still in the name

Largest holder

$2.94M

MILLENNIUM MANAGEMENT LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MILLENNIUM MANAGEMENT LLC1.84M$2.94MHeld
Vanguard292.8K$468.4KHeld
OAKTREE CAPITAL MANAGEMENT LP241.2K$385.9KHeld
GEODE CAPITAL MANAGEMENT, LLC206.2K$329.9KHeld
JONES FINANCIAL COMPANIES LLLP137.7K$220.3KHeld
JANE STREET GROUP, LLC127.5K$204KHeld
Fidelity90.3K$144.5KHeld
BlackRock, Inc.84.4K$135KHeld
State Street63.2K$101.1KHeld
Man Group plc56.8K$90.9KHeld
Oaktree Fund Advisors, LLC42.9K$68.7KHeld
HighTower Advisors, LLC41K$65.6KHeld
NORTHERN TRUST CORP38.4K$61.4KHeld
UBS Group AG38.3K$61.3KHeld
DIVERSIFY WEALTH MANAGEMENT, LLC15K$30.8KHeld
TWO SIGMA SECURITIES, LLC17.1K$27.3KHeld
OSAIC HOLDINGS, INC.15.7K$25.2KHeld
Engineers Gate Manager LP12.3K$19.7KHeld
Portfolio Strategies, Inc.12.2K$19.5KHeld
CITIGROUP INC12.1K$19.3KHeld
IFP Advisors, Inc4.37K$6.99K−$4.2KCut−$4.2K
WELLS FARGO & COMPANY/MN4.33K$6.92KHeld
GROUP ONE TRADING LLC3.19K$5.1KHeld
Caitong International Asset Management Co., Ltd1.64K$2.63KHeld
MORGAN STANLEY1.46K$2.34K−$1.41KCut−$1.86K
BANK OF AMERICA CORP /DE/1.45K$2.31K−$1.39KCut−$15.3K
NewEdge Advisors, LLC1.33K$2.13KHeld
SBI Securities Co., Ltd.169$270Held
Washington Trust Advisors, Inc.160$256Held
GSA CAPITAL PARTNERS LLP120.1K$192Held
Parkside Financial Bank & Trust112$180Held
Annis Gardner Whiting Capital Advisors, LLC112$180Held
EverSource Wealth Advisors, LLC60$96Held
JPMORGAN CHASE & CO45$72Held
Farther Finance Advisors, LLC25$40Held
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO21$34Held
HRT FINANCIAL LP18.1K$28Held
BNP PARIBAS FINANCIAL MARKETS12$19Held
Zurcher Kantonalbank (Zurich Cantonalbank)2$3Held
Triumph Capital Management1$2New
US BANCORP \DE\1$2Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.